Skip to content
healthcare.dev

MESALAMINE

NDC 0527-3012, mesalamine, tablet, delayed release, from Lannett Company Inc..

Product NDC
0527-3012
Status
Listed
Labeler
Lannett Company Inc.
Dosage form
TABLET, DELAYED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA217337
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0527-3012 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • MESALAMINE1.2 g/1

Pharmacologic classes

Aminosalicylate [EPC]; Aminosalicylic Acids [CS]

Package NDCNDC-11Package
0527-3012-4800527301248120 TABLET, DELAYED RELEASE in 1 BOTTLE (0527-3012-48)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/29dbe417-15a9-4c4d-846b-81cabda7ac70
  • NADAC price for package 00527301248

    GET /v1/drugs/nadac/00527301248

Use it

Look up 0527-3012 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0527-3012 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0527-3012. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.